All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
Status | Trial ID | Title | Completion date | Category |
---|---|---|---|---|
Listed as ongoing, but also has a completion date | 2010-018980-41 | International randomized phase III study on the treatment of children and adolescents with refractory or relapsed acute myeloid leukemia | 2020-08-01 | bad-data |
Not reported Terminated | 2013-000018-39 | Clinical trial for the treatment of acute myeloid leukemia in children and adolescents Klinische Prüfung zur Behandlung der akuten myeloischen Leukämien bei Kindern und Jugendlichen | 2019-03-01 | due-trials |
Other | 2017-002935-40 | International cooperative prospective study for children and adolescents with standard risk ALK-positive anaplastic large cell lymphoma (ALCL) estimating the efficacy of Vinblastine | not-yet-due | |
Completed, report not yet due | 2017-003422-32 | INTERNATIONAL MULTICENTER, OPEN-LABEL, PHASE 2 STUDY TO TREAT MOLECULAR RELAPSE OF PEDIATRIC ACUTE MYELOID LEUKEMIA WITH AZACITIDINE | 2023-12-15 | not-yet-due |
Other | 2018-000533-13 | Randomized multi-centre open-label non-inferiority phase 3 clinical trial for patients with a stage IV childhood renal tumour comparing upfront Vincristine, Actinomycin-D and Doxorubicin (VAD, standar... | not-yet-due |